International Journal of Clinical Practice

Am I bothered?
pp. 631-631(1)

Overactive bladder made ridiculously simple?
pp. 631-633(3)

One man and his scope
pp. 633-634(2)

Less patient discomfort by one-man colonoscopy examination
pp. 635-638(4)
Authors: Lee, I-L; Wu, C-S

Cardiac safety of rivastigmine in Lewy body and Parkinson's disease dementias
pp. 639-645(7)
Authors: Ballard, C; Lane, R; Barone, P; Ferrara, R; Tekin, S

Treatment effects of rivastigmine on cognition, performance of daily living activities and behaviour in Alzheimer's disease in an outpatient geriatric setting
pp. 646-654(9)
Authors: Frankfort, S. V.; Appels, B. A.; De Boer, A.; Tulner, L. R.; Van Campen, J. P. C. M.; Koks, C. H. W.; Beijnen, J. H.

Which thyroid-stimulating hormone level should be sought in hypothyroid patients underl-thyroxine replacement therapy?
pp. 655-659(5)
Authors: Gursoy, A.; Ozduman Cin, M.; Kamel, N.; Gullu, S.

Optimisation of thyroid hormone replacement using an automated thyroid register
pp. 660-664(5)
Authors: Cuthbertson, D. J.; Flynn, R.; Jung, R. T.; Leese, G. P.

Bacteriology swab in primary total hip arthroplasty – does it have a role?
pp. 665-666(2)
Authors: Mehra, A.; Hemmady, M. V.; Nelson, R.; Hodgkinson, J. P.

An integrated care pathway to save the critically ischaemic diabetic foot
pp. 667-669(3)
Authors: El Sakka, K.; Fassiadis, N.; Gambhir, R. P. S.; Halawa, M.; Zayed, H.; Doxford, M.; Greensitt, C.; Edmonds, M.; Rashid, H.

Seroprevalence of hepatitis C in patients with type 2 diabetes mellitus and non-diabetic on haemodialysis
pp. 670-674(5)
Authors: Ocak, S.; Duran, N.; Kaya, H.; Emi˙r, İ.

Bax, bcl-2 and c-kit expression in non-small-cell lung cancer and their effects on prognosis
pp. 675-682(8)
Authors: Yaren, A.; Oztop, I.; Kargi, A.; Ulukus, C.; Onen, A.; Sanli, A.; Binicier, O.; Yilmaz, U.; Alakavuklar, M.

Left and right ventricular diastolic functions in patients with rheumatoid arthritis without clinically evident cardiovascular disease
pp. 683-688(6)
Authors: Rexhepaj, N.; Bajraktari, G.; Berisha, I.; Beqiri, A.; Shatri, F.; Hima, F.; Elezi, S.; Ndrepepa, G.

Optimising adjuvant endocrine treatment of breast cancer with aromatase inhibitors
pp. 689-693(5)
Author: Fentiman, I. S.

Treatment of premature ejaculation
pp. 694-697(4)
Authors: Riley, A.; Segraves, R. T.

Review of clinical trials using early acute intervention with oral triptans for migraine management
pp. 698-706(9)
Authors: DOWSON, A. J.; MATHEW, N. T.; PASCUAL, J.

Clinical evidence for use of acetyl salicylic acid in control of flushing related to nicotinic acid treatment
pp. 707-715(9)
Authors: Oberwittler, H.; Baccara-Dinet, M.

Statins and the acute coronary syndrome: `the early bird catches the worm'
pp. 716-727(12)
Authors: Nair, P.; Roguin, A.

Inhaled insulin: new technology, new possibilities
pp. 728-734(7)
Authors: BELLARY, S.; BARNETT, A. H.

A review of gastrointestinal foreign bodies
pp. 735-739(5)
Authors: Ayantunde, A. A.; Oke, T.

Short course of linezolid treatment for vancomycin-resistant Enterococcus faecium meningitis
pp. 740-741(2)
Authors: Tsai, T-N; Wu, C-P; Peng, M-Y; Giian, C-F; Lee, S-Y; Lu, J-J

Abdominal malignancy masquerading as gastro-oesophageal reflux
pp. 742-743(2)
Authors: Gladman, L. M.; Gorard, D. A.

Metoclopramide is not an analgesic: reflection on a premature scientific conclusion
pp. 744-744(1)

Symptom-specific efficacy of tolterodine extended release in patients with overactive bladder: the IMPACT trial
pp. 745-751(7)
Authors: ELINOFF, V.; BAVENDAM, T.; GLASSER, D. B.; CARLSSON, M.; EYLAND, N.; ROBERTS, R.

Tolterodine extended release improves patient-reported outcomes in overactive bladder: results from the IMPACT trial
pp. 752-758(7)
Authors: ROBERTS, R.; BAVENDAM, T.; GLASSER, D. B.; CARLSSON, M.; EYLAND, N.; ELINOFF, V.